Literature DB >> 19108575

Vasodilation of intramuscular arterioles under shear stress in dystrophin-deficient skeletal muscle is impaired through decreased nNOS expression.

K Sato1, T Yokota, S Ichioka, M Shibata, S Takeda.   

Abstract

Duchenne muscular dystrophy (DMD) is a lethal X-linked disorder of striated muscle caused by the absence of dystrophin. Recently, impairment of vascular dilation under shear stress has been found in DMD, but the underlying molecular mechanism is not fully understood. Moreover, dilation of intramuscular arterioles, which may be a key to the molecular pathogenesis, has not been addressed yet. We examined dilation of arterioles in the mouse cremaster muscle under shear stress due to ligation. The vasodilation was significantly impaired in dystrophin-deficient mdx mice as well as in neuronal nitric oxide synthase (nNOS)-deficient mice; however, neither endothelial NOS-deficient mice nor alpha1-syntrophin-deficient mice showed any difference in vasodilation from control mice. These results indicate that nNOS is the main supplier of nitric oxide in shear stress-induced vasodilation in skeletal muscle, but that the sarcolemmal localization of nNOS is not indispensable for the function. In contrast, the response to acetylcholine or sodium nitroprusside was not impaired in mdx or nNOS-deficient mice, suggesting that pharmacological treatment using a vasoactive agent may ameliorate skeletal and cardiac muscle symptoms of DMD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19108575      PMCID: PMC2859605     

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  32 in total

1.  Microvascular and interstitial PO(2) measurements in rat skeletal muscle by phosphorescence quenching.

Authors:  M Shibata; S Ichioka; J Ando; A Kamiya
Journal:  J Appl Physiol (1985)       Date:  2001-07

2.  An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy.

Authors:  S Baez
Journal:  Microvasc Res       Date:  1973-05       Impact factor: 3.514

Review 3.  Association of neuronal nitric oxide synthase (nNOS) with alpha1-syntrophin at the sarcolemma.

Authors:  Y Miyagoe-Suzuki; S I Takeda
Journal:  Microsc Res Tech       Date:  2001-11-01       Impact factor: 2.769

4.  Excessive microvascular adaptation to changes in blood flow in mice lacking gene encoding for desmin.

Authors:  Laurent Loufrani; Zhenlin Li; Bernard I Lévy; Denise Paulin; Daniel Henrion
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

5.  Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats.

Authors:  J C Frisbee; D W Stepp
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-09       Impact factor: 4.733

6.  Impaired vasomodulation is associated with reduced neuronal nitric oxide synthase in skeletal muscle of ovariectomized rats.

Authors:  Paul J Fadel; Weiying Zhao; Gail D Thomas
Journal:  J Physiol       Date:  2003-03-28       Impact factor: 5.182

7.  Topical application of amrinone (a selective phosphodiesterase III inhibitor) for relief of vasospasm.

Authors:  S Ichioka; T Nakatsuka; N Ohura; Y Sato; K Harii
Journal:  J Surg Res       Date:  2000-09       Impact factor: 2.192

8.  Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin.

Authors:  L Loufrani; K Matrougui; D Gorny; M Duriez; I Blanc; B I Lévy; D Henrion
Journal:  Circulation       Date:  2001-02-13       Impact factor: 29.690

9.  Vasomodulation by skeletal muscle-derived nitric oxide requires alpha-syntrophin-mediated sarcolemmal localization of neuronal Nitric oxide synthase.

Authors:  Gail D Thomas; Philip W Shaul; Ivan S Yuhanna; Stanley C Froehner; Marvin E Adams
Journal:  Circ Res       Date:  2003-02-13       Impact factor: 17.367

10.  A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.

Authors:  M Wehling; M J Spencer; J G Tidball
Journal:  J Cell Biol       Date:  2001-10-01       Impact factor: 10.539

View more
  15 in total

1.  Structural Basis of Neuronal Nitric-oxide Synthase Interaction with Dystrophin Repeats 16 and 17.

Authors:  Anne-Elisabeth Molza; Khushdeep Mangat; Elisabeth Le Rumeur; Jean-François Hubert; Nick Menhart; Olivier Delalande
Journal:  J Biol Chem       Date:  2015-09-16       Impact factor: 5.157

2.  Nitric oxide-dependent attenuation of noradrenaline-induced vasoconstriction is impaired in the canine model of Duchenne muscular dystrophy.

Authors:  Kasun Kodippili; Chady H Hakim; Hsiao T Yang; Xiufang Pan; N Nora Yang; Maurice H Laughlin; Ronald L Terjung; Dongsheng Duan
Journal:  J Physiol       Date:  2018-09-20       Impact factor: 5.182

3.  Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice.

Authors:  Mayank Verma; Yoko Asakura; Hiroyuki Hirai; Shuichi Watanabe; Christopher Tastad; Guo-Hua Fong; Masatsugu Ema; Jarrod A Call; Dawn A Lowe; Atsushi Asakura
Journal:  Hum Mol Genet       Date:  2010-08-12       Impact factor: 6.150

4.  Antisense Oligonucleotide Treatment in a Humanized Mouse Model of Duchenne Muscular Dystrophy and Highly Sensitive Detection of Dystrophin Using Western Blotting.

Authors:  Rika Maruyama; Toshifumi Yokota
Journal:  Methods Mol Biol       Date:  2021

5.  Evidence for impaired neurovascular transmission in a murine model of Duchenne muscular dystrophy.

Authors:  Pooneh Bagher; Dongsheng Duan; Steven S Segal
Journal:  J Appl Physiol (1985)       Date:  2010-11-25

6.  Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Justin M Percival; Nicholas P Whitehead; Marvin E Adams; Candace M Adamo; Joseph A Beavo; Stanley C Froehner
Journal:  J Pathol       Date:  2012-07-18       Impact factor: 7.996

7.  Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.

Authors:  Ju Lan Chun; Robert O'Brien; Min Ho Song; Blake F Wondrasch; Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2012-12-27       Impact factor: 6.940

8.  The NO donor sodium nitroprusside: evaluation of skeletal muscle vascular and metabolic dysfunction.

Authors:  Daniel M Hirai; Steven W Copp; Scott K Ferguson; Clark T Holdsworth; Timothy I Musch; David C Poole
Journal:  Microvasc Res       Date:  2012-11-19       Impact factor: 3.514

9.  Dystrophin deficiency promotes leukocyte recruitment in mdx mice.

Authors:  Simon Alexander Kranig; Raphaela Tschada; Maylis Braun; Christian Patry; Johannes Pöschl; David Frommhold; Hannes Hudalla
Journal:  Pediatr Res       Date:  2019-05-15       Impact factor: 3.756

10.  Dystrophin deficiency impairs vascular structure and function in the canine model of Duchenne muscular dystrophy.

Authors:  Kasun Kodippili; Pamela K Thorne; M Harold Laughlin; Dongsheng Duan
Journal:  J Pathol       Date:  2021-06-14       Impact factor: 9.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.